Literature DB >> 21951705

Type 2 polarized immune response holds a major position in Epstein-Barr virus-related idiopathic thrombocytopenic purpura (EBV-ITP).

C-Q Jin1, F Liu, H-X Dong, J Zhang, J-W Zhou, L Song, H Xiao, B-Y Zheng.   

Abstract

INTRODUCTION: Dysfunctional cellular immunity is considered to be essential to the pathophysiology of Epstein-Barr virus-related idiopathic thrombocytopenic purpura (EBV-ITP). Cytokines in peripheral blood and the gene expression of transcription factors in T lymphocytes of patients with were investigated to correlate the polarization of T helper cell type 1 (Th1)/T helper cell type 2 (Th2) with the degree of thrombocytopenia.
METHODS: The expression of type 1 (T-bet) and type 2 (GATA-3) in T lymphocytes was detected by semiquantitative reverse-transcription-polymerase chain reaction, and plasma cytokine levels were measured by enzyme-linked immunoassay in 35 patients and 30 control subjects.
RESULTS: Th1/Th2 [(interleukin-2 + γ-interferon)/(interleukin-10 + interleukin-13)] cytokine ratios and transcription factor (T-bet/GATA-3) mRNA ratios were significantly decreased in patients with EBV-ITP, and the Th1/Th2 ratio was directly correlated with platelet counts.
CONCLUSION: Our findings clearly show that type 2 polarization of the autoimmune response accounts for the expression of cytokines and transcription factors in EBV-ITP.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951705     DOI: 10.1111/j.1751-553X.2011.01375.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  2 in total

1.  Acute immune thrombocytopenic purpura as adverse reaction to oral polio vaccine (OPV).

Authors:  Cheng-qiang Jin; Hai-xin Dong; Zhuo-xiang Sun; Jian-wei Zhou; Cui-yun Dou; Shu-hua Lu; Rui-rui Yang
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

2.  Immune thrombocytopenia: serum cytokine levels in children and adults.

Authors:  Srđana Culić; Ilza Salamunić; Paško Konjevoda; Slavica Dajak; Jasminka Pavelić
Journal:  Med Sci Monit       Date:  2013-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.